Brief: XSpray Pharma: Successful Submission Of IND Application To FDA
Oct 4 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* XSPRAY - SUCCESSFUL SUBMISSION OF IND APPLICATION TO FDA
* ANNOUNCES THAT FDA HAS ACCEPTED COMPANY'S SUBMISSION OF
IND
APPLICATION FOR HYNAP-DASA
Source text for Eikon: ID:nWkr7zMbSR
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003